WE IMPROVE PEOPLE'S LIVES

leading healthcare innovation

A COMPANY WITH MORE THAN 150 YEARS OF HISTORY

that offers solutions adapted to the needs of our clients.

Latest News

Get to know PRIM

2022

PRIM in a minute

Leader in the hospital and orthopaedic supplies market as well as in physiotherapy, thalassotherapy, spa, rehabilitation, geriatric and technical aid services. Its structure aims to strengthen the development of its cultural and business values: its commitment to its customer service quality, its loyalty and its transparency with suppliers, as well as good governance and social liability with employees and with the Company as a whole.

Business Areas

Medical Technology

We offer healthcare professionals a wide range of products and services based on the latest innovative technology.

Mobility & Healthcare

We provide mobility, autonomy and healthcare solutions that improve people’s quality of life.

We are with you in your day-to-day

1

Plastic Surgery

2

Neuromodulation

3

Operating Theatre

4

Endosurgery

5

Neurotrauma

6

ENT

7

Cardiovascular and Radiology Treatment

8

Orthopaedic

9

Orthopedic Establishments

10

Physio

11

Pharma

PRIM IN A MINUTE

1+1

Registered Office
and Headquarters

8

Branches

5

Factories

12

Orthopaedic Centres

2

Manufacturing workshops

Data updated as of 12/31/2022

PRIM IN A MINUTE

Revenue

197 M

Turnover

17.7 M

EBITDA

8.4 M

Net Operating Profit

Datos actualizados a fecha 31/12/2022

PRIM IN A MINUTE

805

Employees

3,447

Suppliers

44%

Green Energy

1,944 t CO2

Emissions Reach 1

365 t CO2

Emissions Reach 2

Datos actualizados a fecha 31/12/2022

PRIM has its headquarters and an important network of branches in Spain. It also has an international presence through its export network that operates in more than 72 countries.

PRIM consolidates the pace of its revenue growth with an almost 9% increase in the first nine months of the year

The Company achieved an 11.2% increase in EBITDA, amounting to an accumulated €17.7 million in the third quarter.   The PRIM Group has strengthened its growth during the first nine months of the year, with an 8.8% increase in…

PRIM joins forces with the HM Hospitals Research Foundation to enhance the early detection of neurodegenerative diseases

  Both institutions have agreed to conduct research in order to corroborate the usefulness of the ocular motility of the Oscann™ device for the early and progressive diagnosis of Alzheimer's and Parkinson's disease. The research…

PRIM and AURA Innovative Robotics Join Forces to Revolutionise the Early Diagnosis of Neurological Diseases

According to data from the Spanish Society of Neurology (SEN), neurological diseases affect more than 7 million people in Spain. Their early diagnosis is essential to improve the prognosis and quality of life for patients and to provide…

Social Media

This post is also available in: Spanish

©2021 PRIM S.A. | Av. del Llano Castellano, 43, 28034 Madrid, España | T: +34 91 334 24 00 | E: info@prim.es
Skip to content